Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-0.79%
3m+1.57%
6m-11.55%
1yr+17.28%
Volume Change (%)
10d/3m+36.14%
Price vs... (%)
52w High-56.09%
50d MA-6.14%
200d MA-24.68%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)25.64
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.93
Price to Tang. Bookn/a
Price to Free Cashflow1.33
Price to Sales0.24
EV to EBITDA3.87

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital13.52%
Return on Equity26.14%
Operating Margin10.97%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Medexus Pharmaceuticals EPS forecast chart

Profile Summary

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA. Medexus Pharma Canada division is a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. The division’s prescription products include Metoject (Methotrexate Injection), Rupall (Rupatadine), Cuvposa (Glycopyrrolate Oral Solution), Pediapharm Naproxen Suspension (Naproxen) and others. Medexus Pharma USA division is a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States. The division’s products include Rasuvo, IXINITY and Gleolan.

Directors

    Last Annual
    March 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    April 1st, 2021
    Public Since
    March 3rd, 2012
    No. of Employees
    98
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    ca flag iconToronto Stock Exchange
    Shares in Issue
    24,458,213

    MDP Share Price Performance

    Upcoming Events for MDP

    Medexus Pharmaceuticals Inc Annual Shareholders Meeting

    Similar to MDP

    Picture of Aurora Cannabis logo

    Aurora Cannabis

    ca flag iconToronto Stock Exchange

    Picture of Auxly Cannabis logo

    Auxly Cannabis

    ca flag iconToronto Stock Exchange

    Picture of Bausch Health Companies logo

    Bausch Health Companies

    ca flag iconToronto Stock Exchange

    Picture of Canopy Growth logo

    Canopy Growth

    ca flag iconToronto Stock Exchange

    Picture of Charlotte's Web Holdings logo

    Charlotte's Web Holdings

    ca flag iconToronto Stock Exchange

    FAQ